360
Participants
Start Date
July 30, 2018
Primary Completion Date
September 30, 2020
Study Completion Date
April 28, 2023
Tislelizumab
Administered intravenously as described
Paclitaxel
Administered intravenously as described
Nab-paclitaxel
Administered intravenously as described
Carboplatin
Administered intravenously as described
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
Beijing Cancer Hospital, Beijing
Peking Union Medical College Hospital, Beijing
Chinese Pla General Hospital, Beijing
Beijing Chest Hospital, Capital Medical University, Beijing
Liaoning Cancer Hospital and Institute, Shenyang
The First Hospital of Jilin University, Changchun
Harbin Medical University Cancer Hospital, Harbin
Shanghai Chest Hospital, Shanghai
General Hospital of Eastern Theater Command, Nanjing
The First Affiliated Hospital of Soochow University, Suzhou
Xuzhou Central Hospital, Xuzhou
Anhui Provincial Hospital, Hefei
The First Affiliated Hospital of Anhui Medical University, Hefei
Qilu Hospital of Shandong University, Jinan
Jinan Central Hospital, Jinan
Jinan Military General Hospital, Jinan
Shandong Cancer Hospital, Jinan
Weifang Peoples Hospital, Weifang
Tianjin Medical University General Hospital, Tianjin
Tianjin Medical University Cancer Institute and Hospital, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Hangzhou First Peoples Hospital, Hangzhou
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Fujian Cancer Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Xiamen
The Second Affiliated Hospital of Chongqing Medical University, Chongqing
Southwest Hospital, Chongqing
Daping Hospital, Third Military Medical University, Chongqing
Chongqing Three Gorges Central Hospital, Chongqing
The Second Xiangya Hospital of Central South University, Changsha
Hunan Cancer Hospital, Changsha
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Hubei Cancer Hospital, Wuhan
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Nanfang Hospital of Southern Medical University, Guangzhou
Cancer Hospital of Shantou University Medical College, Shantou
The Peoples Hospital of Guangxi Zhuang Autonomous Region, Nanning
The Affiliated Hospital of Zunyi Medical College, Zunyi
West China Hospital, Sichuan University, Chengdu
The First Affiliated Hospital of Xian Jiaotong University, Xi'an
Lead Sponsor
BeiGene
INDUSTRY